Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp. CNC, -5.15% , a Medicaid managed care organization, said Wednesday it will help distribute 25,000 COVID-19 test kits per week that have been developed by Quest Diagnostics Inc.

Centene to distribute Quest's COVID-19 tests at health centers

Centene Corporation (CNC) CEO Michael Neidorff on Q1 2020 Results - Earnings Call Transcript

The managed care company's revenue beat wasn't enough to overcome its lower-than-expected earnings and a relatively weak full-year outlook.

What's Behind Centene's Disappointing Q1 Update

Centene's (CNC) Q1 results reflect muted earnings due to lower investment income and incremental senior note interest expense.

Centene's (CNC) Q1 Earnings Miss Estimates, Decline Y/Y

Centene fell from buy range, after earnings missed Wall Street estimates on higher health costs. UnitedHealth, Humana and Cigna, all near buy points, also fell.

Centene Stock Falls From Buy Range On Earnings Miss, Drags Down A-Rated Health Insurers

Centene (CNC) delivered earnings and revenue surprises of -15.69% and 6.96%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Centene (CNC) Q1 Earnings Lag Estimates

Shares of Centene (NYSE:CNC) were unchanged in pre-market trading after the company reported Q1 results.

Centene: Q1 Earnings Insights

Centene (CNC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for Centene (CNC) This Earnings Season?

Humana

CNC vs. HUM: Which Stock Is the Better Value Option?

CNC vs. HUM: Which Stock Should Value Investors Buy Now?

Centene's (CNC) Q1 results are likely to reflect escalating expenses, partially offset by higher revenues.

What's in the Cards for Centene's (CNC) Earnings in Q1?

As of late, it has definitely been a great time to be an investor Centene Corporation

Will Centene Continue to Surge Higher?

Anthem

Molina Healthcare

Select Medical Holdings

HMO Industry: Bullish Near-Term Outlook Despite Coronavirus Impact

Lockheed Martin

Sirius XM Holdings Inc

Sempra Energy

Travelers

Despite coronavirus-induced economic disaster and stock market turmoil, five large-cap (market capital >$20 billion) stocks are poised to beat first-quarter earnings estimates this month.

5 Stocks Poised to Beat on Q1 Earnings Amid Coronavirus Woes

Cigna

Magellan Health

UnitedHealth Group

Health insurers are likely to gain from a solid revenue base, attributable to higher premiums across Medicare, Medicaid plans.

7 Health Insurers Poised to Beat Earnings Estimates in Q1

Evergy Inc

MarketAxess Holdings

Newmont Mining

Paycom Software

The S&P 500 has seen its best week since 1974. These stocks beat the index healthily and also holds potential for future outperformance.

S&P 500's Best Week Since 1974: 5 Winners With High Potential

Akamai Technologies

Amazon

Activision Blizzard

Biogen

DexCom

Electronic Arts

Equinix

Hormel Foods

ICU Medical

Johnson & Johnson

LogMeIn

Netflix

NETGEAR

RingCentral

J. M. Smucker

Vertex Pharmaceuticals

Zscaler

The best large-cap industries are electronic gaming, drugmakers, gold, packaged foods, and healthcare plans.

Here Are The Best Large-Cap Stocks To Buy Now

Centene's (CNC) strategic initiatives and higher membership might aid its revenues to perk up its share price in turn.

Centene Soars 47.8% in Six Months: Will the Rally Continue?

Shares of Centene Corp. CNC, +2.95% fell 3% in premarket trading on Wednesday after the company said it will cover the cost of COVID-19-related screening, testing, and for people who have its Medicare, Medicaid and health insurance exchange plans.

Centene to cover cost of COVID-19 care for Medicare, Medicaid patients

Centene (CNC) reported earnings 30 days ago. What's next for the stock?

Centene (CNC) Down 5.5% Since Last Earnings Report: Can It Rebound?

The IBD SmartSelect Composite Rating for Centene rose from 88 to 96 Thursday. 
The post Highly Rated Centene Stock Joins An Elite List appeared first on Investor's Business Daily.

Highly Rated Centene Stock Joins An Elite List

Centene (CNC) updates its 2020 outlook that reflects its WellCare buyout and the potential Medicaid rate decrease.

Centene (CNC) Reduces 2020 Earnings Estimates, Shares Slide

Centene Corp. CNC, -2.54% shares fell 3.8% in the extended session Tuesday after the health-care manager tweaked its guidance for 2020 to reflect an acquisition and said it could face a rate reduction.

Centene tweaks 2020 guidance, warns of potential rate decrease

HCA Healthcare

Tenet Healthcare

Disparity in the regulatory policies of presidential candidates of various parties renders volatility to the healthcare sector.

Healthcare Sector to Remain Volatile in 2020 Amid Elections

A Relative Strength Rating upgrade for Centene shows improving technical performance.
The post Centene Clears Technical Benchmark, Hitting 80-Plus RS Rating appeared first on Investor's Business Daily.

Centene Clears Technical Benchmark, Hitting 80-Plus RS Rating

Health insurer Centene will be on the lookout for potential acquisitions after integrating its biggest-ever purchase in WellCare Health Plans.

News for Centene Stock (CNC)